NCT06876909View on ClinicalTrials.gov

Clinical Effect Observation of Barley Green Intervention in Hyperuricemia Population and Related Mechanism Study of Xanthine Oxidase

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 26, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Hyperuricemia
Interventions
DIETARY_SUPPLEMENT

barley green

Oral administration: 30 minutes before meals Dosage: 4 g powder, 5 g tablet Frequency: 2 times a day

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT06876909 - Clinical Effect Observation of Barley Green Intervention in Hyperuricemia Population and Related Mechanism Study of Xanthine Oxidase | Biotech Hunter | Biotech Hunter